Updates are available Correction dated 2021-08-04
Click to view Correction: https://doi.org/10.1038/s41598-021-95556-9
-
Authors
Diaz, Miguel F.
Horton, Paulina D.
Dumbali, Sandeep P.
Kumar, Akshita
Livingston, Megan
Skibber, Max A.
Mohammadalipour, Amina
Gill, Brijesh S.
Zhang, Songlin
Cox, Charles S. Jr.
Wenzel, Pamela L.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK111599, R01DK111599)
State of Texas (Emerging Technology Fund, Emerging Technology Fund)
American Society of Hematology (Scholar Award)
- License Information
-
More Information
Article History
Received: 29 April 2020
Accepted: 4 December 2020
First Online: 17 December 2020
Change Date: 4 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-95556-9
Competing interests
: B.S.G., C.S.C., and P.L.W. are inventors on a patent for conditioning of stem and progenitor cells for cellular therapy (U.S. Patent US20180187141A1). All other authors declare no conflict of interest.
